CVS Coram: Revolutionizing Pharmacy With Unmatched Convenience - do3
Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.
Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.
Webcvs caremark corporation (nyse:cvs) recently completed the $2. 1 billion acquisition of drug infusion services provider coram llc.
Recommended for you
Webdrugstore chain cvs caremark corp.
🔗 Related Articles You Might Like:
Amazing Lash Studio Bloomingdale Home Depot's Criminal Conspiracy: Employees And Outsiders Colluded Uncover Hidden Gems: Discover Exclusive For-Sale-by-Owner Listings In Orange County📸 Image Gallery
You may also like